Brain Health Patient Safety Learning Laboratory

脑健康患者安全学习实验室

• 批准号: 9059908
• 负责人: CHRISTOPHER M CALLAHAN
• 金额: $ 94.88万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-30 至 2019-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9059908
• 关键词: Brain; Health; Patient; Safety; Learning

 DESCRIPTION (provided by applicant): We are proposing to establish the Brain Health Patient Safety Learning Laboratory ("Brain Safety Lab") at the Indiana University School of Medicine in collaboration with the Indiana University School of Informatics and Computing, The Indiana University School of Nursing, The Purdue University Schools of Biomedical and Industrial Engineering, the Purdue College of Pharmacy, the Regenstrief Institute, Inc., and a safety net health care system, Eskenazi Health. The Brain Safety Lab will allow this new professional network to brainstorm about solutions to brain safety and to rapidly deploy and test novel ideas in real-world clinical settings serving vulnerable elders. Vulnerable elders, includin low-income and minority elders and those who suffer from multimorbility, are AHQ priority populations The specific aim of this proposal is to establish a patient safety learning laboratory focused on preventing harms to brain health among an AHRQ priority population at high risk for avoidable harm. Brain health is one of the highest priorities for successful aging. Brain health includes both cognitive and emotional health as well as positive sense of well-being. Within the context of brain health, we will focus initially on patient safety harms related to the use of medications among older adults. Use of medications that have the potential to harm brain health is widely accepted as a patient safety problem that has been resistant to early intervention efforts. The institute of Medicine recently issued a report on cognitive aging that included a call for joint an collaborative actions among policy-makers, health care professionals, patients, and families to "review patient medications, paying attention to medications known to have an impact on cognition." We focus on older adults because they are the largest reservoir of medication use, over-use, and misuse and are particularly vulnerable to brain safety concerns.

 描述（由申请人提供）：我们提议与印第安纳大学信息与计算学院、印第安纳大学护理学院、普渡大学生物医学和工业工程学院、普渡大学药学院、Regenstrief Institute, Inc. 以及安全网医疗保健系统 Eskenazi Health 合作，在印第安纳大学医学院建立脑健康患者安全学习实验室（“脑安全实验室”）。 大脑安全实验室将使这个新的专业网络能够集思广益，讨论大脑安全的解决方案，并在为弱势老年人服务的现实临床环境中快速部署和测试新想法。 弱势老年人，包括低收入老年人、少数族裔老年人以及患有多种疾病的老年人，是 AHQ 的优先关注人群 该提案的具体目标是建立一个患者安全学习实验室，重点关注预防 AHRQ 优先人群中可避免伤害高风险人群的大脑健康受到损害。 大脑健康是成功老龄化的首要任务之一。 大脑健康包括认知和情绪健康以及积极的幸福感。 在大脑健康的背景下，我们将首先关注与老年人用药相关的患者安全危害。 使用可能损害大脑健康的药物被广泛认为是一个患者安全问题，且早期干预努力一直受到抵制。 医学研究所最近发​​布了一份关于认知衰老的报告，其中呼吁政策制定者、医疗保健专业人员、患者和家庭联合采取协作行动，“审查患者的药物，关注已知对认知有影响的药物”。 我们关注老年人，因为他们是药物使用、过度使用和误用的最大储存库，并且特别容易受到大脑安全问题的影响。